Skip to main content
. 2023 May 19;40(7):3087–3103. doi: 10.1007/s12325-023-02497-y

Table 3.

Relative efficacy of ponatinib vs. imatinib—complete molecular response

CMR MDACC vs. GRAAPH-2005 MDACC vs. NCT00038610 GIMEMA LAL1811 vs. CSI57ADE10
OR (95% CI) p-value OR (95% CI) p value OR (95% CI) p value
Unadjusted comparison 12.34 (5.77, 26.41) < 0.001 4.93 (2.13, 11.39) < 0.001 7.65 (2.48, 23.64) < 0.001
Population-adjusted comparison 12.11 (3.77, 38.87) < 0.001 5.65 (2.02, 15.76) < 0.001 6.20 (1.60, 24.00) 0.008

CI confidence interval, CMR complete molecular response, OR odds ratio